355 results on '"Cupelli, Luca"'
Search Results
2. Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies
3. Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin’s lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study
4. P971: EFFECT OF DARATUMUMAB ON STEM CELL YIELDS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: REPORT FROM THE MULTIPLE MYELOMA LAZIO GROUP.
5. Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions
6. Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs
7. Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice
8. Autologous stem cell transplantation in multiple myeloma patients over 70 years: AGIMEMALazio Working Group experience in a retrospective case–control study
9. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
10. Transfusions at home in patients with myelodysplastic syndromes
11. An unusual case of follicular dendritic cell sarcoma of the omentum with pleomorphous morphology and aberrant cytokeratin expression
12. Controversies on Antibiotic Lock Technique Duration: Experience with a 3-Day Course for Hematological Patients
13. Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group
14. Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy?
15. Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation
16. Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study.
17. Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting
18. Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma
19. Efficacy and Safety of Nepa in Preventing Nausea and Vomiting Induced by Multiple-day Chemotherapy in Patients With Refractory/relapsed Aggressive Non-hodgkin’s Lymphoma Undergoing Stem Cell Mobilization Prior to Autologous Hematopoietic Stem Cell Transplantation
20. Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey
21. Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes
22. Multidimensional Vascular Evaluation in Patients Treated with Tyrosine Kinase Inhibitors (TKIs): From Plaque Formation to Evolution and Follow up on 150 Patients
23. Dysgeusia in patients with hematological malignancies: a reminder for hematologist
24. The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature
25. The Prevention of Oral Mucositis in Patients with Blood Cancers: Current Concepts and Emerging Landscapes
26. Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
27. Koebner’s phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview
28. Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA)
29. Epidemiology and pathogenesis of incident pain-related disability in malignant hematology: an Italian survey
30. Management of hematological malignancies in patients affected by renal failure
31. Pain in malignant hematology
32. Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience
33. Bortezomib-related colon mucositis in a multiple myeloma patient
34. Phase II Multicenter, Not Comparative, Study of Multiple Doses of NEPA (netupitant + palonosetron) in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Non-Hodgkin Lymphoma Patients Eligible for Autologous Hematopoietic Stem Cell Transplantation Receiving Multiple Days / High Dose Chemotherapy Regimens
35. Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma
36. Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkinʼs lymphoma patients
37. Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report
38. Idiopathic thrombocytopenic purpura coexisting with polycythemia vera
39. Bone marrow aspiration and biopsy-related pain management
40. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
41. Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy
42. Gingival myeloid sarcoma in myelodysplastic syndrome
43. Necrotizing fasciitis in myelodysplastic syndrome: an exceptionally rare occurrence
44. Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score
45. Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant
46. Motor disability in the setting of oral anticoagulant therapy
47. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation
48. Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program
49. Rapid response and sustained remission by rituximab in four cases of plasma-exchange-failed acute thrombotic thrombocytopenic purpura
50. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.